AI Generated Image
Alzheimer's patient in Broward sees brain plaques cleared after year and a half of treatment
CBS News • • health
Key Points:
- Scott Milinsky, diagnosed with Alzheimer's like his father, has found hope through a new medication called Kisunla, which targets and removes amyloid plaques in the brain.
- Kisunla, developed by Eli Lilly, aims to slow early symptomatic Alzheimer's progression by breaking up amyloid plaques, a key feature of the disease.
- After 18 infusions over 18 months, Milinsky's PET scan showed the amyloid plaques were gone, marking a significant milestone in his treatment.
- Dr. Hazel Wiley emphasized that while Kisunla is not a cure—since it doesn't address TAU tangles—it represents a meaningful advancement in Alzheimer's care.
- The Memory Disorder & Alzheimer's Center at Broward Health North is currently treating over 60 patients with Kisunla, offering new hope for those affected by the disease.
